Skip to main content
CORT
NASDAQ Life Sciences

Corcept Resubmits Key Cushing's Syndrome Drug NDA; FDA Decision Expected in Six Months

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$64
Mkt Cap
$6.48B
52W Low
$28.66
52W High
$91
52W Position info
123% above low
Off High info
30% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CORT has more than doubled off its 52-week low of $28.66.

Summary

Corcept has resubmitted its New Drug Application (NDA) for relacorilant as a treatment for Cushing's Syndrome patients. This follows a previous Complete Response Letter from the FDA for relacorilant in hypercortisolism, as noted in the company's last 10-K. The resubmission is a material step towards potential approval for a key drug in a new indication, addressing a prior regulatory setback. The FDA expects to set a PDUFA date six months after the NDA resubmission.

At the time of this announcement, CORT was trading at $64.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.5B. The 52-week trading range was $28.66 to $91.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CORT - Latest Insights

CORT
Nov 03, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.50
Real-time Price: $63.27 info
Change: -$15.23 (-19%) info
Market Cap: $6.9B info
CORT
Nov 03, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $81.93
Real-time Price: $63.27 info
Change: -$18.66 (-23%) info
Market Cap: $6.9B info
CORT
Oct 26, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $86.01
Real-time Price: $63.27 info
Change: -$22.74 (-26%) info
Market Cap: $6.9B info
CORT
Oct 20, 2026, 4:00 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $116.51
Real-time Price: $63.27 info
Change: -$53.23 (-46%) info
Market Cap: $6.9B info
CORT
Sep 18, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $114.90
Real-time Price: $63.27 info
Change: -$51.63 (-45%) info
Market Cap: $6.9B info